Pei-Chun Chen

Title: Pei-Chun Chen: Innovator in Esophageal Cancer Treatment

Introduction

Pei-Chun Chen is a notable inventor based in Taipei, Taiwan. She has made significant contributions to the field of cancer research, particularly in the area of esophageal cancer treatment. Her innovative work focuses on improving patient outcomes through genetic research.

Latest Patents

Pei-Chun Chen holds a patent for "Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy." This invention relates to novel genetic markers associated with the response of a patient with esophageal cancer (ECa) to chemoradiation therapy. The patent outlines methods and kits for predicting an ECa patient's response to chemoradiation therapy by genotyping these markers. She has 1 patent to her name.

Career Highlights

Pei-Chun Chen is affiliated with National Taiwan University, where she conducts her research and develops her innovative ideas. Her work has garnered attention in the medical community for its potential to enhance treatment strategies for esophageal cancer patients.

Collaborations

Pei-Chun Chen collaborates with esteemed colleagues, including Liang-Chuan Lai and Jang-Ming Lee. These partnerships contribute to the advancement of research in cancer treatment and the development of new therapeutic approaches.

Conclusion

Pei-Chun Chen's contributions to the field of esophageal cancer treatment through her innovative patent demonstrate her commitment to improving patient care. Her work exemplifies the importance of research and innovation in the medical field.